LIDOCAINE EFFICACY AND TOXICITY ASSESSED BY A NEW, RAPID METHOD

被引:22
作者
BUCKMAN, K [1 ]
CLAIBORNE, K [1 ]
GUZMAN, MD [1 ]
WALBERG, CB [1 ]
HAYWOOD, LJ [1 ]
机构
[1] UNIV SO CALIF,LOS ANGELES CTY MED CTR,LOS ANGELES,CA 90033
关键词
D O I
10.1038/clpt.1980.147
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:177 / 181
页数:5
相关论文
共 18 条
[1]   USE OF LIDOCAINE BY CONTINUOUS INFUSION [J].
BASSAN, MM ;
WEINSTEIN, SR ;
MANDEL, WJ .
AMERICAN HEART JOURNAL, 1974, 87 (03) :302-303
[2]  
COBB ME, 1977, CLIN CHEM, V23, P1161
[3]   CLINICAL PHARMACOLOGY OF LIDOCAINE AS AN ANTIARRHYTHMIC DRUG [J].
COLLINSWORTH, KA ;
KALMAN, SM ;
HARRISON, DC .
CIRCULATION, 1974, 50 (06) :1217-1230
[4]   ANALYSIS OF LIDOCAINE AND ITS POSTULATED METABOLITES [J].
DIFAZIO, CA ;
BROWN, RE .
ANESTHESIOLOGY, 1971, 34 (01) :86-&
[5]   PROGNOSTIC FEATURES OF VENTRICULAR TACHYCARDIA COMPLICATING ACUTE MYOCARDIAL-INFARCTION [J].
DURAIRAJ, SK ;
VENKATARAMAN, K ;
DEGUZMAN, M ;
HAYWOOD, LJ .
JOURNAL OF ELECTROCARDIOLOGY, 1977, 10 (04) :305-312
[6]   PHARMACOKINETIC APPROACH TO CLINICAL USE OF LIDOCAINE INTRAVENOUSLY [J].
GREENBLATT, DJ ;
BOLOGNINI, V ;
KOCHWESER, J ;
HARMATZ, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (03) :273-277
[7]   SHOULD LIDOCAINE BE ADMINISTERED ROUTINELY TO ALL PATIENTS AFTER ACUTE MYOCARDIAL-INFARCTION [J].
HARRISON, DC .
CIRCULATION, 1978, 58 (04) :581-584
[8]  
KIMBALL JOHN T., 1968, PROG CARDIOV DIS, V10, P483, DOI 10.1016/0033-0620(68)90001-7
[9]   LIDOCAINE IN PREVENTION OF PRIMARY VENTRICULAR-FIBRILLATION - DOUBLE-BLIND, RANDOMIZED STUDY OF 212 CONSECUTIVE PATIENTS [J].
LIE, KI ;
WELLENS, HJ ;
VANCAPEL.FJ ;
DURRER, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (25) :1324-1326
[10]   CLINICAL USE AND TOXICITY OF INTRAVENOUS LIDOCAINE - REPORT FROM BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM [J].
PFEIFER, HJ ;
GREENBLATT, DJ ;
KOCHWESER, J .
AMERICAN HEART JOURNAL, 1976, 92 (02) :168-173